Zhejiang Jiuzhou Pharmaceutical Co., Ltd. 2025 Annual Equity Distribution Implementation Announcement
Securities code: 603456 Securities abbreviation: Jiuzhou Pharmaceutical Announcement number: 2026-033 Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
Annual Equity Distribution Implementation Announcement
2025
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
Important content reminder:
Distribution ratio per share
Cash dividend per A share is 0.10 yuan.
Relevant dates
Class of shares Equity registration date Last trading day Ex-rights (dividend) date Cash dividend payment date
A shares 2026/6/10 - 2026/6/11 2026/6/11 Differentiated dividend transfer: Yes
1. The session and date of the shareholders’ meeting that approved the distribution plan
This profit distribution plan was reviewed and approved by the company's 2025 annual shareholders' meeting on May 18, 2026.
2. Distribution plan
Issuance year: 2025
Assign objects:
As of the closing of the Shanghai Stock Exchange in the afternoon of the equity registration day, all shareholders of the company registered with the Shanghai Branch of China Securities Depository and Clearing Co., Ltd. (hereinafter referred to as "China Clearing Shanghai Branch").
According to relevant laws, administrative regulations, departmental rules and other normative documents such as the "Company Law of the People's Republic of China" (hereinafter referred to as the "Company Law"), the Securities Law of the People's Republic of China (hereinafter referred to as the "Securities Law"), the "Shanghai Stock Exchange Self-Regulatory Supervision Guidelines for Listed Companies No. 7 on Repurchases of Shares" and the relevant provisions of the "Articles of Association", the shares repurchased by the company do not enjoy the rights to vote at the shareholders' meeting, profit distribution, transfer of reserve funds to share capital, subscription of new shares and allotment of shares.
- Differentiated dividend transfer plan:
(1) This differentiated dividend plan
On May 18, 2026, the company's 2025 annual shareholders' meeting reviewed and approved the following differentiated equity distribution plan: The company plans to use the company's total share capital of 889,446,028 shares as of March 31, 2026, minus the special account for repurchase There are 7,736,000 shares, that is, based on 881,710,028, a cash dividend of RMB 1.00 (tax included) will be distributed to all shareholders for every 10 shares, and a total cash dividend of RMB 88,171,002.80 (tax included) is planned.
The total amount of the company's cash dividends in 2025 (including cash dividends distributed in the interim) is 264,513,008.40 yuan; the share repurchase funds that have been implemented in 2025 are cash as consideration and centralized bidding. The total amount of cash dividends and repurchases is 366,504,079.40 yuan, accounting for 50.20% of the net profit attributable to shareholders of listed companies in 2025.
If the company's total share capital changes due to share repurchase and share cancellation between the date of announcement and the equity registration date for equity distribution, the company plans to maintain the per share distribution ratio unchanged and adjust the total distribution accordingly. If the total share capital changes subsequently, specific adjustments will be announced separately. For details, please refer to the "Announcement of Zhejiang Jiuzhou Pharmaceutical Co., Ltd. on the 2025 Annual Profit Distribution Plan and the 2026 Interim Dividend Authorization" disclosed by the company on the Shanghai Stock Exchange website (www.sse.com.cn) on April 24, 2026.
(2) Calculation basis for this differentiated dividend ex-rights and ex-dividends
According to the relevant regulations of the Shanghai Stock Exchange, the company calculates the ex-rights (dividend) opening reference price according to the following formula:
Ex-rights (dividend) reference price = (previous closing price - cash dividend) ÷ (1 + change ratio of circulating shares)
(1) Since the company carries out differentiated dividends this time, the cash dividend in the above formula refers to the cash dividend per share calculated based on the dilution adjustment of the total share capital. The calculation formula is as follows: cash dividend per share = (total share capital participating in distribution × actual cash dividend per share distributed) ÷ total share capital = (881,710,028 × 0.10) ÷ 889,446,028 ≈ 0.10 yuan/share.
(2) The company will only distribute cash dividends this time, without bonus shares or capitalization distribution. The company’s circulating shares will not change, and the change ratio of circulating shares is 0.
To sum up, the ex-rights (dividend) reference price = (previous closing price - 0.10) ÷ (1 + 0) = (previous closing price - 0.10) yuan/share.
3. Relevant dates
Class of shares Equity registration date Last trading day Ex-rights (dividend) date Cash dividend payment date
A shares 2026/6/10 - 2026/6/11 2026/6/11
4. Distribution Implementation Methods
- Implementation measures
(1) Except for shareholders to whom the company distributes cash dividends on its own, dividends from shares without selling restrictions are entrusted to the Shanghai Branch of China Securities Settlement Co., Ltd. to be distributed through its fund clearing system to shareholders who are registered after the Shanghai Stock Exchange closes on the equity registration date and have completed designated transactions with each member of the Shanghai Stock Exchange. Investors who have completed designated transactions can receive cash dividends at their designated securities business department on the dividend distribution date. Shareholder dividends that have not completed designated transactions will be temporarily kept by China Securities Clearing Company Shanghai Branch and will be distributed after designated transactions are completed.
(2) The company’s repurchase of shares in the special securities account will not participate in profit distribution.
- Issue objects by yourself
The cash dividends of Zhejiang Zhongbei Jiuzhou Group Co., Ltd., Taizhou Goethe Industrial Co., Ltd., Hua Lirong, and Lin Huilu will be distributed by the company itself in accordance with relevant regulations.
- Tax deduction instructions
(1) For individual shareholders and securities investment funds who hold the company's unrestricted tradable shares, according to the relevant provisions of the "Notice on Issues Concerning the Implementation of Differentiated Personal Income Tax Policies on Dividends and Bonuses of Listed Companies" (Caishui [2012] No. 85) and the "Notice on Issues Concerning the Differentiated Personal Income Tax Policy on Dividends and Bonuses of Listed Companies" (Caishui [2015] No. 101), listed companies will not withhold personal income tax for the time being, and the actual cash dividend per share will be RMB 0.10.
When individual shareholders and securities investment funds transfer stocks, CSDC Shanghai Branch will calculate the actual tax payable based on their shareholding period (referring to the holding period from the date when individuals and securities investment funds obtain company stocks from the public issuance and transfer market to the day before the date of transfer and delivery of company stocks). The amount will be deducted from the personal capital account by securities companies and other stock custody institutions and transferred to China Clearing Shanghai Branch. China Clearing Shanghai Branch will transfer it to the listed company within 5 working days of the next month. The company will declare and pay to the competent tax authorities within the statutory reporting period of the month in which the tax is received. The specific actual tax burden is: if the shareholder's shareholding period is less than one month (including one month), the full amount of dividends and bonus income will be included in the taxable income, and the actual tax burden is 20%; if the shareholding period is from more than one month to one year (inclusive), the taxable income will be included in the taxable income at a temporarily reduced rate of 50%, and the actual tax burden will be 10%; if the shareholding period exceeds one year, personal income tax will be temporarily exempted.
(2) For Qualified Foreign Institutional Investors (QFIIs), the Company, in accordance with the provisions of the "Notice on Issues Concerning the Withholding and Payment of Corporate Income Tax on Dividends, Dividends and Interests paid by Chinese Resident Enterprises to QFIIs" (Guo Shui Han [2009] No. 47) promulgated by the State Administration of Taxation, Corporate income tax is uniformly withheld and paid at a tax rate of 10%, and an actual cash dividend of RMB 0.09 per share after tax is distributed; if it believes that the dividend income received needs to enjoy the benefits of a tax agreement (arrangement), it can apply to the competent tax authorities on its own after receiving dividends and dividends in accordance with regulations.
(3) For Hong Kong market investors (including enterprises and individuals) who hold company stocks through Shanghai-Hong Kong Stock Connect, their cash dividends will be distributed by the company through the Shanghai Branch of China Securities Clearing Co., Ltd. according to the account of the nominal holder of the stock (Hong Kong Securities Clearing Company Limited). According to the provisions of the Notice on Tax Policies for the Pilot Program of the Shanghai-Hong Kong Stock Market Interconnection Mechanism (Caishui [2014] No. 81), the Company withholds income tax at a rate of 10%, and actually distributes a cash dividend of RMB 0.09 per share after tax.
(4) For other institutional investors and legal person shareholders, the company will not withhold and pay the cash dividend income tax by themselves. The actual cash dividend distributed is RMB 0.10 per share.
5. Consultation methods
If you have any questions about this equity distribution, please contact us according to the following contact information:
Contact Department: Investment and Securities Department
Contact number: 0576-88706789
Announcement is hereby made.
Board of Directors of Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
June 5, 2026